OBIO – orchestra biomed holdings, inc. - ordinary shares (US:NASDAQ)
Stock Stats
News
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Orchestra BioMed (NASDAQ:OBIO) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs [Yahoo! Finance]
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock [Yahoo! Finance]
Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at TD Cowen. They set a "buy" rating and a $15.00 price target on the stock.
Form 8-K Orchestra BioMed Holding For: Jan 12
Form 4 Orchestra BioMed Holding For: Jan 02 Filed by: Aiello Joshua
Form 4 Orchestra BioMed Holding For: Jan 02 Filed by: Taylor Andrew Lawrence
Form 4 Orchestra BioMed Holding For: Jan 02 Filed by: Sherman Darren
Form 4 Orchestra BioMed Holding For: Dec 10 Filed by: Taylor Andrew Lawrence
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.